TABLE 3.
Age (yr) | Total
|
February-May
|
October-December
|
Pb | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | No. positive | % Positive | RRa | n | No. positive | % Positive | RR | n | No. positive | % Positive | RR | ||
0-3 | 694 | 22 | 3.2c | 1.0 | 346 | 15 | 4.3d,e | 1.0 | 348 | 7 | 2.0 | 1.0 | 0.13 |
4-17 | 679 | 10 | 1.5 | 0.46 | 339 | 4 | 1.2d | 0.26 | 340 | 6 | 1.8 | 0.88 | 0.76 |
≥18 | 671 | 5 | 0.8c | 0.23 | 335 | 2 | 0.6e | 0.13 | 336 | 3 | 0.9 | 0.44 | 0.99 |
Total | 2,044 | 37 | 1.8 | 1,020 | 21 | 2.1 | 1,024 | 16 | 1.6 | 0.50 | |||
P for trend | 0.0008 | 0.0006 | 0.24 |
RR, relative risk.
Significance of the differences in the prevalence rates found in each age group between the two study periods.
P = 0.003.
P = 0.022.
P = 0.004.